EPIC-SR trial: In fully vaccinated patients with risk factors for severe disease and patients (vaccinated or unvaccinated) without such risk factors, nirmatrelvir–ritonavir did not significantly shorten the time to alleviation of Covid-19 symptoms. *****wkheIsqMyupic.twitter.com/NocUZxcxb6
https://bbs.wenxuecity.com/myhouse/13433143.html
那位好像有点肠激综合症,天天吃什么混合粉,姜黄粉什么的。我得试试咱中华神药。~